P887: IN-HOUSE ANTI BCMA CAR-T THERAPY FOR THE TREATMENT OF RELAPSED REFRACTORY MULTIPLE MYELOMA: PHASE 1 RESULTS.

Nathalie Asherie; Shlomit Kfir-Erenfeld; Batia Avni; Sigal Grisariu; Miri Assayag; Taly Sharon; Eyal Lebel; Cyrille J. Cohen; Moshe E. Gatt; Polina Stepensky

doi:10.1097/01.hs9.0000846424.39371.7a

P887: IN-HOUSE ANTI BCMA CAR-T THERAPY FOR THE TREATMENT OF RELAPSED REFRACTORY MULTIPLE MYELOMA: PHASE 1 RESULTS.

Nathalie Asherie
, Shlomit Kfir-Erenfeld
, Batia Avni
, Sigal Grisariu
, Miri Assayag
, Taly Sharon
, Eyal Lebel
, Cyrille J. Cohen
, Moshe E. Gatt
, Polina Stepensky

Research output: Contribution to journal › Article › peer-review

Original language	English GB
Pages (from-to)	1490-1491
Journal	HemaSphere
DOIs	https://doi.org/10.1097/01.hs9.0000846424.39371.7a
State	Published - 1 Jun 2022

Access to Document

10.1097/01.hs9.0000846424.39371.7aLicense: CC BY-NC-ND

Cite this

@article{adde032fbe9d480282d93582b3c13e59,

title = "P887: IN-HOUSE ANTI BCMA CAR-T THERAPY FOR THE TREATMENT OF RELAPSED REFRACTORY MULTIPLE MYELOMA: PHASE 1 RESULTS.",

author = "Nathalie Asherie and Shlomit Kfir-Erenfeld and Batia Avni and Sigal Grisariu and Miri Assayag and Taly Sharon and Eyal Lebel and Cohen, \{Cyrille J.\} and Gatt, \{Moshe E.\} and Polina Stepensky",

year = "2022",

month = jun,

day = "1",

doi = "10.1097/01.hs9.0000846424.39371.7a",

language = "الإنجليزيّة",

pages = "1490--1491",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "John Wiley and Sons Inc",

}

TY - JOUR

T1 - P887: IN-HOUSE ANTI BCMA CAR-T THERAPY FOR THE TREATMENT OF RELAPSED REFRACTORY MULTIPLE MYELOMA: PHASE 1 RESULTS.

AU - Asherie, Nathalie

AU - Kfir-Erenfeld, Shlomit

AU - Avni, Batia

AU - Grisariu, Sigal

AU - Assayag, Miri

AU - Sharon, Taly

AU - Lebel, Eyal

AU - Cohen, Cyrille J.

AU - Gatt, Moshe E.

AU - Stepensky, Polina

PY - 2022/6/1

Y1 - 2022/6/1

U2 - 10.1097/01.hs9.0000846424.39371.7a

DO - 10.1097/01.hs9.0000846424.39371.7a

M3 - مقالة

SN - 2572-9241

SP - 1490

EP - 1491

JO - HemaSphere

JF - HemaSphere

ER -